A gene variant may help improve survival rates for individuals with idiopathic pulmonary fibrosis (IPF) and could inform the use of certain medications. Meanwhile, separate research suggests that socioeconomic status may impact outcomes for IPF patients. The relationship between these factors and IPF outcomes is being explored in different studies.